D. Jaeger

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial

P. Sharma, P. Ott, J. Rosenberg, 2016 .

Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment

M. Kloor, B. Müller-Stich, L. Sisic, 2022, Journal of Cancer Research and Clinical Oncology.

Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trial.

N. Halama, T. Weber, C. Springfeld, 2022, European journal of cancer.

Efficacy of exercise training in SCT patients-who benefits most?

C. Ulrich, M. Bohus, P. Dreger, 2014, Bone Marrow Transplantation.

Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment

M. Kloor, B. Müller-Stich, L. Sisic, 2022, Journal of Cancer Research and Clinical Oncology.

Exercise and cancer: return to work as a firefighter with ostomy after rectal carcinoma – a case report

J. Wiskemann, F. Scharhag-Rosenberger, Kai Schommer, 2016, Medicine.

How reproducible are methods to measure the dynamic viscoelastic properties of poroelastic media?

Hamid Ahmadi, Christ Glorieux, Franck Sgard, 2018, Journal of Sound and Vibration.

Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib® versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]

C. von Kalle, C. Heining, H. Glimm, 2008, BMC Cancer.